UniProt ID | RHOB_HUMAN | |
---|---|---|
UniProt AC | P62745 | |
Protein Name | Rho-related GTP-binding protein RhoB | |
Gene Name | RHOB | |
Organism | Homo sapiens (Human). | |
Sequence Length | 196 | |
Subcellular Localization |
Late endosome membrane Lipid-anchor. Cell membrane Lipid-anchor. Nucleus. Cleavage furrow. Late endosomal membrane (geranylgeranylated form). Plasma membrane (farnesylated form). Also detected at the nuclear margin and in the nucleus. Translocates |
|
Protein Description | Mediates apoptosis in neoplastically transformed cells after DNA damage. Not essential for development but affects cell adhesion and growth factor signaling in transformed cells. Plays a negative role in tumorigenesis as deletion causes tumor formation. Involved in intracellular protein trafficking of a number of proteins. Targets PKN1 to endosomes and is involved in trafficking of the EGF receptor from late endosomes to lysosomes. Also required for stability and nuclear trafficking of AKT1/AKT which promotes endothelial cell survival during vascular development. Serves as a microtubule-dependent signal that is required for the myosin contractile ring formation during cell cycle cytokinesis. Required for genotoxic stress-induced cell death in breast cancer cells.. | |
Protein Sequence | MAAIRKKLVVVGDGACGKTCLLIVFSKDEFPEVYVPTVFENYVADIEVDGKQVELALWDTAGQEDYDRLRPLSYPDTDVILMCFSVDSPDSLENIPEKWVPEVKHFCPNVPIILVANKKDLRSDEHVRTELARMKQEPVRTDDGRAMAVRIQAYDYLECSAKTKEGVREVFETATRAALQKRYGSQNGCINCCKVL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
7 | Ubiquitination | -MAAIRKKLVVVGDG -CCCCCCEEEEECCC | 36.34 | 29967540 | |
19 | Phosphorylation | GDGACGKTCLLIVFS CCCCCCCEEEEEEEE | 8.15 | 21712546 | |
26 | Phosphorylation | TCLLIVFSKDEFPEV EEEEEEEECCCCCCE | 28.44 | 21712546 | |
34 | Phosphorylation | KDEFPEVYVPTVFEN CCCCCCEECCCEEEC | 10.07 | 22817900 | |
34 | O-linked_Glycosylation | KDEFPEVYVPTVFEN CCCCCCEECCCEEEC | 10.07 | 24141704 | |
37 | O-linked_Glycosylation | FPEVYVPTVFENYVA CCCEECCCEEECEEE | 27.99 | 24905543 | |
37 | Phosphorylation | FPEVYVPTVFENYVA CCCEECCCEEECEEE | 27.99 | 23532336 | |
41 | ADP-ribosylation | YVPTVFENYVADIEV ECCCEEECEEEEEEE | 25.72 | - | |
41 | ADP-ribosylation | YVPTVFENYVADIEV ECCCEEECEEEEEEE | 25.72 | - | |
42 | Phosphorylation | VPTVFENYVADIEVD CCCEEECEEEEEEEC | 6.99 | - | |
51 | Ubiquitination | ADIEVDGKQVELALW EEEEECCEEEEEEEE | 46.86 | 16196087 | |
60 | Phosphorylation | VELALWDTAGQEDYD EEEEEEECCCCCCHH | 22.55 | 29978859 | |
66 | Phosphorylation | DTAGQEDYDRLRPLS ECCCCCCHHHCCCCC | 11.38 | 25884760 | |
73 | Phosphorylation | YDRLRPLSYPDTDVI HHHCCCCCCCCCCEE | 36.98 | - | |
104 | Ubiquitination | EKWVPEVKHFCPNVP HHHCCHHHHHCCCCC | 29.33 | 32015554 | |
118 | Ubiquitination | PIILVANKKDLRSDE CEEEEECHHHCCCCH | 37.62 | 32015554 | |
123 | Phosphorylation | ANKKDLRSDEHVRTE ECHHHCCCCHHHHHH | 55.43 | 20873877 | |
129 | Phosphorylation | RSDEHVRTELARMKQ CCCHHHHHHHHHHHC | 33.97 | - | |
135 | Ubiquitination | RTELARMKQEPVRTD HHHHHHHHCCCCCCC | 46.05 | 23000965 | |
154 | Phosphorylation | MAVRIQAYDYLECSA EEEEEEEEEEECCCC | 6.69 | 19060867 | |
156 | Phosphorylation | VRIQAYDYLECSAKT EEEEEEEEECCCCCC | 7.54 | 27642862 | |
159 | S-palmitoylation | QAYDYLECSAKTKEG EEEEEECCCCCCHHH | 4.41 | 29575903 | |
162 | Ubiquitination | DYLECSAKTKEGVRE EEECCCCCCHHHHHH | 43.78 | 32015554 | |
185 | Phosphorylation | ALQKRYGSQNGCINC HHHHHHCCCCCCCCC | 16.13 | 22817900 | |
189 | S-palmitoylation | RYGSQNGCINCCKVL HHCCCCCCCCCEEEC | 2.37 | 15713677 | |
192 | S-palmitoylation | SQNGCINCCKVL--- CCCCCCCCEEEC--- | 0.90 | 15713677 | |
193 | Farnesylation | QNGCINCCKVL---- CCCCCCCEEEC---- | 2.71 | 7713879 | |
193 | Geranylgeranylation | QNGCINCCKVL---- CCCCCCCEEEC---- | 2.71 | 7713879 | |
193 | Methylation | QNGCINCCKVL---- CCCCCCCEEEC---- | 2.71 | 1400319 | |
193 | S-palmitoylation | QNGCINCCKVL---- CCCCCCCEEEC---- | 2.71 | 29575903 | |
193 | Farnesylation | QNGCINCCKVL---- CCCCCCCEEEC---- | 2.71 | 7713879 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
185 | S | Phosphorylation | Kinase | CSNK1A1 | P48729 | GPS |
- | K | Ubiquitination | E3 ubiquitin ligase | NEDD4L | Q96PU5 | PMID:26949039 |
- | K | Ubiquitination | E3 ubiquitin ligase | KCTD10 | Q9H3F6 | PMID:29358211 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RHOB_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RHOB_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CTRO_HUMAN | CIT | physical | 8543060 | |
ARHG3_HUMAN | ARHGEF3 | physical | 12221096 | |
RHPN2_HUMAN | RHPN2 | physical | 12473120 | |
GDIR3_HUMAN | ARHGDIG | physical | 8939998 | |
BACD2_HUMAN | TNFAIP1 | physical | 19637314 | |
RAC1_HUMAN | RAC1 | physical | 25301945 | |
CUL2_HUMAN | CUL2 | physical | 25540389 | |
RBX1_HUMAN | RBX1 | physical | 25540389 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Methylation | |
Reference | PubMed |
"Post-translational modifications of p21rho proteins."; Adamson P., Marshall C.J., Hall A., Tilbrook P.A.; J. Biol. Chem. 267:20033-20038(1992). Cited for: PALMITOYLATION AT CYS-189 AND CYS-192, ISOPRENYLATION AT CYS-193,METHYLATION AT CYS-193, AND MUTAGENESIS OF CYS-189; CYS-192; CYS-193AND LYS-194. | |
Palmitoylation | |
Reference | PubMed |
"Post-translational modifications of p21rho proteins."; Adamson P., Marshall C.J., Hall A., Tilbrook P.A.; J. Biol. Chem. 267:20033-20038(1992). Cited for: PALMITOYLATION AT CYS-189 AND CYS-192, ISOPRENYLATION AT CYS-193,METHYLATION AT CYS-193, AND MUTAGENESIS OF CYS-189; CYS-192; CYS-193AND LYS-194. | |
Prenylation | |
Reference | PubMed |
"CAAX geranylgeranyl transferase transfers farnesyl as efficiently asgeranylgeranyl to RhoB."; Armstrong S.A., Hannah V.C., Goldstein J.L., Brown M.S.; J. Biol. Chem. 270:7864-7868(1995). Cited for: ISOPRENYLATION AT CYS-193, AND MUTAGENESIS OF CYS-192 AND CYS-193. | |
"Post-translational modifications of p21rho proteins."; Adamson P., Marshall C.J., Hall A., Tilbrook P.A.; J. Biol. Chem. 267:20033-20038(1992). Cited for: PALMITOYLATION AT CYS-189 AND CYS-192, ISOPRENYLATION AT CYS-193,METHYLATION AT CYS-193, AND MUTAGENESIS OF CYS-189; CYS-192; CYS-193AND LYS-194. |